Thomas Lingelbach, Valneva CEO
Covid-19 roundup: Valneva runs into EMA questions, still expects March authorization; Canada approves first plant-based vaccine
In February 2021, the European Medicines Agency began a rolling review of French biotech Valneva’s Covid-19 vaccine, which is a whole virus, inactivated, adjuvanted vaccine …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
